The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News BPC 157 and Erectile Dysfunction: What the Evidence Actually Shows Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review